-
Supreme Court Expands Presidential Control Over Independent Agencies
07/07/2026
In a pair of rulings that will potentially reshape the regulatory landscape, the U.S. Supreme Court permitted the President to fire the heads of independent agencies—while carving out a notable exception for the Federal Reserve. On June 29, 2026, in Trump v. Slaughter, No. 25-332, the Supreme Court ruled 6-3 that the Federal Trade Commission’s “for-cause” removal provision violated the Constitution’s separation of powers.
Categories:
Bribery,
CFTC,
Civil Enforcement,
Compliance,
Criminal Enforcement,
Department of Justice,
Enforcement Actions,
Exchange Act,
False Claims Act,
FINRA,
Investigations,
Judicial Opinions,
Plea Agreement,
Regulatory Enforcement,
SEC,
Supreme Court,
Whistleblower
-
DOJ And CFTC Charge U.S. Soldier For Insider Trading In Prediction Markets
06/09/2026
On April 23, 2026, the U.S. Department of Justice (“DOJ”) and Commodity Futures Trading Commission (“CFTC”) announced separate enforcement actions against an active-duty member of the U.S. Army, alleging that the soldier utilized non-public information regarding classified U.S. operations related to the capture of Venezuelan President Nicolás Maduro to trade on Polymarket.com, a prediction market website.
-
DOJ Announces Settlement Where Medical Group And Related Parties Will Pay Over $62M To Resolve False Claims Act Suit
04/01/2025
On March 26, the Department of Justice (“DOJ”) announced that a California-headquartered healthcare provider, Seoul Medical Group Inc. (“Seoul Medical”), its former president and majority owner, and a Seoul Medical subsidiary were ordered to pay over $62 million for violating the False Claims Act. According to the DOJ, Seoul Medical allegedly submitted false diagnosis codes to increase payments from the Medicare Advantage Program. A radiology group that also worked with Seoul Medical agreed to pay $2,350,000 for allegedly conspiring with Seoul Medical.